PubMed · 12240621
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
2002. Bloody stool.. https://pubmed.ncbi.nlm.nih.gov/12240621/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
It is well known that nitric oxide (NO), the most important vasodilator agent, plays an important role in lowering vascular resistance in the human umbilical-placental circulation and that its deficiency is related to the pathogenesis of pre-eclamptic disorder. Besides it has recently been demonstrated that human hemoglobin (HbA) is able to transport nitric oxide, as S-nitrosohemoglobin (SNO-Hb), from the arterial to the venous blood. In the present study we examine the functional properties of the adult and fetal nitrosated hemoglobins to see if the double transport of oxygen and NO may influence the fetal oxygenation and the relation between maternal and fetal blood. Our results show that S-nitrosation significantly increases the oxygen affinity of the adult Hb (HbA) with respect to native protein (no-nitrosated) while the functional properties of HbF are less influenced. The oxygen affinity modification, found for SNO-HbA, was ascribed to the nitrosation of cysteine beta 93: really, the same residue is also present in the gamma chains of fetal hemoglobin, while the increase of affinity is less evidenced; hence, it is probable that the 39 aminoacidic substitutions between beta and gamma chains allay the effects of S-nitrosation. As regards the physiological modulators (protons, chloride ions, 2,3-diphosphoglyceric acid, and temperature), they influence the oxygen affinity of the two hemoglobins S-nitrosated, in equal mode with respect to the native forms determining the same variation on the oxygen affinity. Hence, our results evidence the fact that the NO release by SNO-HbA "in vivo" would be limited to regions of extremely low oxygen tension (such as hypoxic regions), while in fetus, SNO-HbF would unload nitric oxide and oxygen at pressure values close to normal.
Using a mathematical approach, we analyzed the behavior of the PD model originally described by Bragg et al. The effect was dose-dependent modified until a maximum value (E(max)) was reached. Further increments in dose prolonged the E(max), but the recovery phase did not increase beyond a calculable asymptope. In the absence of plasma concentrations, it was impossible to distinguish the rate of plasma equilibration with the effect compartment (k(e0)) from the rate of drug elimination (k(e1)). Variations on the sigmoidicity affected both the onset and offset of drug effect. Sigmoidicity and the slowest rate constant had identical effects on the spontaneous reversion of the effect, as judged by the recovery index. The IR(50), the index of potency, merely shifted the dose-response relationship to the left or right. Changes in IR(50) were compensated for by making the same proportional changes in dose.
A method is presented for measuring and verifying the radiation dose in gamma irradiators used for treating blood prior to transfusion. This method employs the iodide/iodate dosimeter (0.6M iodide, 0.1M iodate, and 0.01 borate at pH 9.25) which forms triiodide upon exposure to ionizing radiation; for Cs-137 radiation the G value is 14.1. Samples were placed in a canister and irradiated in a conventional blood bank irradiator containing several Cs-137 sources. The following were exposed: (a) nine 1.5 ml plastic tubes containing dosimetry solution taped inside a 250 ml blood bag, which, in turn, was filled with either water or blood, (b) 50 ml plastic syringes containing varying amounts of dosimetry solution, (c) a whole blood bag containing 250 ml of the dosimetry solution. A water phantom was not used during exposure. The absorbance changes at 352 nm due to triiodide formation were used to determine a dose rate, which was on the order of 10 Gy/min (+/-5%) for all samples measured. This value is consistent with an average time-decayed dose rate for the irradiation volume as determined from the manufacturers calibration of the unit taking into account the heterogeneous nature of the radiation field inside the irradiator and the absence of a water phantom. Because of its sensitivity, ease of operation, and reproducibility, it is suggested that the iodide/iodate dosimetry system be considered for on-site periodic conformation/verification of the radiation dose as part of a quality assurance requirement for blood irradiators.